论文部分内容阅读
原发性肾小球肾炎是指除外全身性疾病引起的肾小球肾炎。其病理类型在膜增殖性肾小球肾炎发病率已有所下降而系膜IgA肾小球肾炎的发病率则相应增加。原发性肾小球肾炎的免疫治疗均以临床经验为根据,至今尚无统一治疗方案,作者复习了近期文献,仅就原发性肾小球肾炎的免疫治疗综述如下。微小病变型肾小球肾炎微小病变型肾小球肾炎的病因及发病机制至今尚不清楚。根据临床经验及实验室研究、目前认为细胞免疫紊乱与本病的发病有关;由于免疫反应是受遗传控制的,通过对本病的遗传因素研究,认为
Primary glomerulonephritis refers to the exception of systemic disease caused by glomerulonephritis. The pathological type in the incidence of proliferative glomerulonephritis has decreased and the incidence of mesangial IgA glomerulonephritis increased accordingly. Immunotherapy of primary glomerulonephritis are based on clinical experience, there is no uniform treatment so far, the author reviewed the recent literature, only the immunotherapy of primary glomerulonephritis are summarized below. The etiology and pathogenesis of minimal change glomerulonephritis minimal change glomerulonephritis is still unclear. According to clinical experience and laboratory studies, currently considered cellular immune disorders and the pathogenesis of this disease; due to immune response is controlled by the genetic factors of this disease through the study, that